1. Home
  2. APRE vs HWH Comparison

APRE vs HWH Comparison

Compare APRE & HWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • HWH
  • Stock Information
  • Founded
  • APRE 2006
  • HWH 2021
  • Country
  • APRE United States
  • HWH United States
  • Employees
  • APRE N/A
  • HWH N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • HWH Other Pharmaceuticals
  • Sector
  • APRE Health Care
  • HWH Health Care
  • Exchange
  • APRE Nasdaq
  • HWH Nasdaq
  • Market Cap
  • APRE 10.0M
  • HWH 8.4M
  • IPO Year
  • APRE 2019
  • HWH N/A
  • Fundamental
  • Price
  • APRE $1.89
  • HWH $1.37
  • Analyst Decision
  • APRE Strong Buy
  • HWH
  • Analyst Count
  • APRE 2
  • HWH 0
  • Target Price
  • APRE $15.50
  • HWH N/A
  • AVG Volume (30 Days)
  • APRE 50.1K
  • HWH 49.0K
  • Earning Date
  • APRE 08-11-2025
  • HWH 08-11-2025
  • Dividend Yield
  • APRE N/A
  • HWH N/A
  • EPS Growth
  • APRE N/A
  • HWH N/A
  • EPS
  • APRE N/A
  • HWH N/A
  • Revenue
  • APRE $1,284,475.00
  • HWH $1,262,664.00
  • Revenue This Year
  • APRE N/A
  • HWH N/A
  • Revenue Next Year
  • APRE N/A
  • HWH N/A
  • P/E Ratio
  • APRE N/A
  • HWH N/A
  • Revenue Growth
  • APRE 33.27
  • HWH 37.84
  • 52 Week Low
  • APRE $1.41
  • HWH $0.90
  • 52 Week High
  • APRE $5.01
  • HWH $7.20
  • Technical
  • Relative Strength Index (RSI)
  • APRE 55.82
  • HWH 51.50
  • Support Level
  • APRE $1.60
  • HWH $1.31
  • Resistance Level
  • APRE $2.22
  • HWH $1.49
  • Average True Range (ATR)
  • APRE 0.17
  • HWH 0.09
  • MACD
  • APRE 0.03
  • HWH -0.00
  • Stochastic Oscillator
  • APRE 46.77
  • HWH 36.67

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About HWH HWH International Inc.

HWH International Inc is and its consolidated subsidiaries operate a food and beverage business in Singapore and South Korea. The F&B business operates four cafes, two of which are located in South Korea and two in Singapore, as well as an online healthy food store, serving customers in Singapore.

Share on Social Networks: